Amazon.com Inc.‘s (NASDAQ:AMZN) Amazon Pharmacy will offer eligible Medicare beneficiaries weight-loss drugs for $50 per month through a new federal program aimed at expanding access
The company announced on Thursday that the service would automate eligibility checks, prior authorizations, and billing, while providing home delivery and in-store pickup to streamline access. Amazon Pharmacy will begin enrollment for eligible patients after they add their insurance and Medicare information and their clinician submits an electronic prescription
The company said that same-day delivery is now available in more than 3,100 U.S. cities and towns and is expected to expand to nearly 4,500 locations by the end of 2026. The company added that many submitted claims have already been fulfilled through completed orders
GLP-1 Becomes a Retail Battleground
In April, Amazon <a href="https://healthylife7.com/leisure-centre-to-get-expanded-fitness-facilities/” title=”Leisure centre to get expanded fitness facilities”>expanded into the weight-loss market with a new GLP-1 management program through Amazon One Medical. The service integrates virtual and in-person care, prescription management, and pharmacy fulfillment to make obesity treatment more accessible and support long-term weight management. The pharmacy stated that it would offer GLP-1 weight-loss medications, including Wegovy and newer oral options
Eric Bormel, managing director specializing in digital healthcare at Solomon Partners’ healthcare grouptoldCNBC, “Retailers are betting that if they can become the front door for obesity care, they’ll earn a relationship that extends far beyond a single GLP-1 prescription.”
Retailers are using direct-to-consumer (DTC) GLP-1 programs primarily to attract customers, while placing greater value on the broader healthcare ecosystem around the drugs as GLP-1 medication prices continue to decline, Bormel said
Market News and Data brought to you by Benzinga APIs
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred
